US5714512A
(en)
*
|
1991-07-08 |
1998-02-03 |
Rhone-Poulenc Rorer, S.A. |
Compositions containing taxane derivatives
|
US5750561A
(en)
*
|
1991-07-08 |
1998-05-12 |
Rhone-Poulenc Rorer, S.A. |
Compositions containing taxane derivatives
|
CA2086874E
(en)
*
|
1992-08-03 |
2000-01-04 |
Renzo Mauro Canetta |
Methods for administration of taxol
|
GB2269319B
(en)
*
|
1992-08-03 |
1997-04-09 |
Bristol Myers Squibb Co |
Methods for administration of taxol
|
CA2308082A1
(en)
|
1992-11-27 |
1994-06-09 |
Paul Handreck |
Injectable compostion
|
US5684169A
(en)
*
|
1992-11-27 |
1997-11-04 |
Ensuiko Sugar Refining Co., Ltd. |
Cyclodextrin inclusion complex of taxol, and method for its production and its use
|
JPH06157330A
(ja)
*
|
1992-11-27 |
1994-06-03 |
Ensuiko Sugar Refining Co Ltd |
タキソールのサイクロデキストリン包接物,その製造法と用途
|
FR2698543B1
(fr)
*
|
1992-12-02 |
1994-12-30 |
Rhone Poulenc Rorer Sa |
Nouvelles compositions à base de taxoides.
|
KR101222904B1
(ko)
*
|
1993-07-19 |
2013-01-17 |
안지오테크 파마슈티칼즈, 인코포레이티드 |
항맥관형성 조성물, 당해 조성물로 피복된 스텐트 및 당해 스텐트의 제조방법
|
US5886026A
(en)
*
|
1993-07-19 |
1999-03-23 |
Angiotech Pharmaceuticals Inc. |
Anti-angiogenic compositions and methods of use
|
US6335356B1
(en)
|
1994-01-07 |
2002-01-01 |
Sugen, Inc. |
Method of treating a patient by parenteral administration of a lipophilic compound
|
US5610173A
(en)
*
|
1994-01-07 |
1997-03-11 |
Sugen, Inc. |
Formulations for lipophilic compounds
|
AU2826495A
(en)
*
|
1994-06-02 |
1996-01-04 |
Enzon, Inc. |
Method of solubilizing substantially water insoluble materials
|
WO1996003113A1
(en)
*
|
1994-07-22 |
1996-02-08 |
G.D. Searle & Co. |
Self-emulsifying drug delivery system
|
US5681846A
(en)
*
|
1995-03-17 |
1997-10-28 |
Board Of Regents, The University Of Texas System |
Extended stability formulations for paclitaxel
|
US6964946B1
(en)
|
1995-10-26 |
2005-11-15 |
Baker Norton Pharmaceuticals, Inc. |
Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
|
US6245805B1
(en)
*
|
1995-10-26 |
2001-06-12 |
Baker Norton Pharmaceuticals, Inc. |
Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
|
AU724842B2
(en)
*
|
1995-12-21 |
2000-09-28 |
Genelabs Technologies, Inc. |
Taxane composition and method
|
KR100191446B1
(ko)
*
|
1996-05-02 |
1999-06-15 |
송영욱 |
파클리탁셀 함유 전신성 홍반성 낭창치료제
|
KR100358934B1
(ko)
*
|
1996-09-13 |
2003-01-29 |
주식회사한국신약 |
탁솔을함유한주사용약제조성물
|
US6515016B2
(en)
|
1996-12-02 |
2003-02-04 |
Angiotech Pharmaceuticals, Inc. |
Composition and methods of paclitaxel for treating psoriasis
|
US6458373B1
(en)
*
|
1997-01-07 |
2002-10-01 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
BR9808697A
(pt)
|
1997-04-28 |
2000-07-11 |
Rhone Poulenc Rorer Sa |
Processo para inibir o crescimento de um tumor, vetor de adenovìrus defeituoso, vetor de vìrus, uso do mesmo, e, composição farmacêutica
|
US6316479B1
(en)
|
1997-05-19 |
2001-11-13 |
Sugen, Inc. |
Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders
|
DE69716485T2
(de)
*
|
1997-05-30 |
2003-04-10 |
Man Woo Han |
Taxol enthaltende pharmazeutische injektionslösung
|
BE1011216A3
(fr)
*
|
1997-06-13 |
1999-06-01 |
Thissen En Abrege L T B Lab |
Forme pharmaceutique pour l'administration de paclitaxel, procede de preparation d'une composition de paclitaxel prete a l'emploi et utilisation de cette composition.
|
US7208010B2
(en)
*
|
2000-10-16 |
2007-04-24 |
Conor Medsystems, Inc. |
Expandable medical device for delivery of beneficial agent
|
US20040254635A1
(en)
*
|
1998-03-30 |
2004-12-16 |
Shanley John F. |
Expandable medical device for delivery of beneficial agent
|
US6241762B1
(en)
|
1998-03-30 |
2001-06-05 |
Conor Medsystems, Inc. |
Expandable medical device with ductile hinges
|
US7208011B2
(en)
*
|
2001-08-20 |
2007-04-24 |
Conor Medsystems, Inc. |
Implantable medical device with drug filled holes
|
US7314637B1
(en)
|
1999-06-29 |
2008-01-01 |
Neopharm, Inc. |
Method of administering liposomal encapsulated taxane
|
WO2000023070A1
(en)
|
1998-10-20 |
2000-04-27 |
Ben Venue Laboratories, Inc. |
Process for purification of solvents useful in the preparation of pharmaceutical compositions
|
US6293967B1
(en)
|
1998-10-29 |
2001-09-25 |
Conor Medsystems, Inc. |
Expandable medical device with ductile hinges
|
US6071952A
(en)
*
|
1998-12-02 |
2000-06-06 |
Mylan Pharmaceuticals, Inc. |
Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents
|
US6290673B1
(en)
|
1999-05-20 |
2001-09-18 |
Conor Medsystems, Inc. |
Expandable medical device delivery system and method
|
FR2794771B1
(fr)
|
1999-06-11 |
2001-08-10 |
Aventis Pharma Sa |
Adenovirus recombinants codant pour le transporteur specifique de l'iode (nis)
|
WO2001024763A2
(en)
|
1999-10-01 |
2001-04-12 |
Immunogen, Inc. |
Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
|
EP1935380B1
(de)
|
2000-10-16 |
2010-05-12 |
Conor Medsystems, Inc. |
Expandierbare medizinische Vorrichtung zur Freisetzung eines Heilmittels
|
US6764507B2
(en)
|
2000-10-16 |
2004-07-20 |
Conor Medsystems, Inc. |
Expandable medical device with improved spatial distribution
|
PL203300B1
(pl)
|
2000-10-31 |
2009-09-30 |
Akad Medyczna |
Stabilna postać farmaceutyczna leku przeciwnowotworowego oraz sposób wytwarzania stabilnej postaci farmaceutycznej leku przeciwnowotworowego
|
WO2002043765A2
(en)
*
|
2000-11-28 |
2002-06-06 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
|
US6964680B2
(en)
*
|
2001-02-05 |
2005-11-15 |
Conor Medsystems, Inc. |
Expandable medical device with tapered hinge
|
US20040073294A1
(en)
*
|
2002-09-20 |
2004-04-15 |
Conor Medsystems, Inc. |
Method and apparatus for loading a beneficial agent into an expandable medical device
|
KR20020079239A
(ko)
*
|
2001-04-14 |
2002-10-19 |
이언식 |
학습기
|
US7056338B2
(en)
*
|
2003-03-28 |
2006-06-06 |
Conor Medsystems, Inc. |
Therapeutic agent delivery device with controlled therapeutic agent release rates
|
US20040249443A1
(en)
*
|
2001-08-20 |
2004-12-09 |
Shanley John F. |
Expandable medical device for treating cardiac arrhythmias
|
KR100774366B1
(ko)
*
|
2001-09-10 |
2007-11-08 |
주식회사 중외제약 |
파클리탁셀 주사제 조성물
|
US20030101058A1
(en)
*
|
2001-11-26 |
2003-05-29 |
Kenneth Liou |
Voice barcode scan device
|
CA2466851C
(en)
*
|
2001-11-26 |
2012-09-11 |
Supergen, Inc. |
Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositions
|
WO2003045357A1
(en)
*
|
2001-11-27 |
2003-06-05 |
Transform Pharmaceuticals, Inc. |
Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof
|
IL163666A0
(en)
|
2002-02-22 |
2005-12-18 |
New River Pharmaceuticals Inc |
Active agent delivery systems and methods for protecting and administering active agents
|
RU2341296C2
(ru)
*
|
2002-05-24 |
2008-12-20 |
Энджиотек Интернэшнл Аг |
Композиции и способы покрытия медицинских имплантатов
|
US8313760B2
(en)
*
|
2002-05-24 |
2012-11-20 |
Angiotech International Ag |
Compositions and methods for coating medical implants
|
US20040127976A1
(en)
*
|
2002-09-20 |
2004-07-01 |
Conor Medsystems, Inc. |
Method and apparatus for loading a beneficial agent into an expandable medical device
|
JP2006500121A
(ja)
*
|
2002-09-20 |
2006-01-05 |
コナー メドシステムズ, インコーポレイテッド |
複数の有益な作用物質の送出用の開口を有する拡張式医療器具
|
KR20050105451A
(ko)
|
2003-02-03 |
2005-11-04 |
네오팜 인코포레이티드 |
안정한 멸균 여과가능한 리포좀 캡슐화 탁산 및 다른항종양제
|
EP2272544A1
(de)
|
2003-03-28 |
2011-01-12 |
Conor Medsystems, Inc. |
Implantierbare medizinische Vorrichtung enthaltend eine therapeutische Substanz in einem Konzentrationsgradient.
|
US7169179B2
(en)
*
|
2003-06-05 |
2007-01-30 |
Conor Medsystems, Inc. |
Drug delivery device and method for bi-directional drug delivery
|
US7785653B2
(en)
*
|
2003-09-22 |
2010-08-31 |
Innovational Holdings Llc |
Method and apparatus for loading a beneficial agent into an expandable medical device
|
US20050158356A1
(en)
*
|
2003-11-20 |
2005-07-21 |
Angiotech International Ag |
Implantable sensors and implantable pumps and anti-scarring agents
|
AU2005100176A4
(en)
*
|
2005-03-01 |
2005-04-07 |
Gym Tv Pty Ltd |
Garbage bin clip
|
JP2008543789A
(ja)
*
|
2005-06-17 |
2008-12-04 |
ホスピラ オーストラリア ピーティーワイ エルティーディー |
ドセタキセルの液体薬学的処方物
|
GB0517092D0
(en)
*
|
2005-08-19 |
2005-09-28 |
Novartis Ag |
New compositions containing taxane derivatives
|
BRPI0600194A
(pt)
|
2006-01-30 |
2007-10-23 |
Quiral Quimica Do Brasil S A |
composições farmacêuticas contendo docetaxel e um inibidor de degradação e processo de obtenção das mesmas
|
WO2008026048A2
(en)
*
|
2006-08-31 |
2008-03-06 |
Wockhardt Research Centre |
Stable injectable pharmaceutical compositions of docetaxel
|
EP1946747A1
(de)
*
|
2007-01-17 |
2008-07-23 |
Sandoz AG |
Taxanderivat enthaltende pharmazeutische Zusammensetzung von verbesserter Stabilität
|
CZ200756A3
(cs)
*
|
2007-01-23 |
2008-07-30 |
Heaton, A. S. |
Dvousložková farmaceutická kompozice obsahující taxan
|
FR2917088B1
(fr)
*
|
2007-06-08 |
2009-09-04 |
Aventis Pharma Sa |
Dissolution directe du docetaxel dans un solvant dans le polysorbate 80
|
MX2009013663A
(es)
*
|
2007-06-22 |
2010-01-27 |
Scidose Llc |
Formulacion solubilizada de docetaxel sin tween 80.
|
US20090076127A1
(en)
*
|
2007-09-19 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched larotaxel
|
FR2922107B1
(fr)
*
|
2007-10-10 |
2010-02-26 |
Aventis Pharma Sa |
Nouvelles compositions a base de taxoides
|
KR101053780B1
(ko)
*
|
2008-02-29 |
2011-08-02 |
동아제약주식회사 |
도세탁셀을 함유하는 단일액상의 안정한 약제학적 조성물
|
ES2344674B1
(es)
|
2008-08-07 |
2011-06-29 |
Gp Pharm, S.A. |
Composicion farmaceutica inyectable de taxanos.
|
US8541360B2
(en)
*
|
2008-11-19 |
2013-09-24 |
Ben Venue Laboratories, Inc. |
Parenteral formulations comprising sugar-based esters and ethers
|
EP2204167A1
(de)
|
2009-01-05 |
2010-07-07 |
Azad Pharma AG |
Pharmazeutische Mikroemulsion zur Prävention von supramolekularer Aggregation von ampiphilen Molekülen
|
US7772274B1
(en)
|
2009-10-19 |
2010-08-10 |
Scidose, Llc |
Docetaxel formulations with lipoic acid
|
US20110092579A1
(en)
*
|
2009-10-19 |
2011-04-21 |
Scidose Llc |
Solubilized formulation of docetaxel
|
US8912228B2
(en)
|
2009-10-19 |
2014-12-16 |
Scidose Llc |
Docetaxel formulations with lipoic acid
|
US8476310B2
(en)
|
2009-10-19 |
2013-07-02 |
Scidose Llc |
Docetaxel formulations with lipoic acid
|
US8541465B2
(en)
*
|
2009-10-19 |
2013-09-24 |
Scidose, Llc |
Docetaxel formulations with lipoic acid and/or dihydrolipoic acid
|
CN102038635A
(zh)
|
2009-10-23 |
2011-05-04 |
天津天士力集团有限公司 |
一种含有pH值调节剂的紫杉烷类药物溶液及其制备方法
|
TWI438009B
(zh)
*
|
2010-02-19 |
2014-05-21 |
Teikoku Pharma Usa Inc |
紫杉烷前-乳劑調配物及其製造與使用之方法
|
CN109745287A
(zh)
|
2010-05-03 |
2019-05-14 |
帝国制药美国公司 |
非水性紫杉烷前-乳剂制剂以及制备和使用该制剂的方法
|
WO2012156999A1
(en)
|
2011-05-19 |
2012-11-22 |
Manu Chaudhary |
Ready to use docetaxel formulation
|
PT2753355T
(pt)
|
2011-09-08 |
2019-02-01 |
Univ New York |
Vírus herpes simplex oncolítico e suas utilizações terapêuticas
|
WO2013096455A1
(en)
|
2011-12-20 |
2013-06-27 |
Dana-Farber Cancer Institute, Inc. |
Methods for diagnosing and treating oncogenic kras-associated cancer
|
JP2013194009A
(ja)
*
|
2012-03-21 |
2013-09-30 |
Nipro Corp |
ドセタキセル製剤
|
CA2874521A1
(en)
|
2012-05-24 |
2013-11-28 |
Dana-Farber Cancer Institute, Inc. |
Targeting the glutamine to pyruvate pathway for treatment of oncogenic kras-associated cancer
|
WO2014014518A1
(en)
|
2012-07-18 |
2014-01-23 |
Dana-Farber Cancer Institute, Inc. |
Methods for treating, preventing and predicting risk of developing breast cancer
|
EP2875814B1
(de)
|
2012-07-19 |
2018-08-22 |
FUJIFILM Corporation |
Flüssige zusammensetzung mit wirkstoff auf taxanbasis, verfahren zur herstellung davon und flüssiges arzneimittel
|
JO3685B1
(ar)
|
2012-10-01 |
2020-08-27 |
Teikoku Pharma Usa Inc |
صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
|
EP2968406A4
(de)
|
2013-03-14 |
2016-10-26 |
Icahn School Med Mount Sinai |
Mit autologem tumorlysat beladener dendritischer zellimpfstoff zur behandlung von leberkrebs
|
EP2777691A1
(de)
*
|
2013-03-14 |
2014-09-17 |
Pharmachemie B.V. |
Taxoid - Reinigung der flüssigen Hilfsstoffen
|
US10130590B2
(en)
|
2013-10-01 |
2018-11-20 |
Dana-Farber Cancer Institute, Inc. |
Methods of treating cancer with atovaquone-related compounds
|
AU2015231001A1
(en)
|
2014-03-21 |
2016-09-29 |
Abbvie Inc. |
Anti-EGFR antibodies and antibody drug conjugates
|
US10350264B2
(en)
|
2014-03-27 |
2019-07-16 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for modulating NCOA4-mediated autophagic targeting of ferritin
|
MA39818A
(fr)
|
2014-03-30 |
2017-02-08 |
Benevir Biopharm Inc |
Virus oncolytiques « armés » comprenant un inhibiteur de tap exogène et leurs utilisations thérapeutiques
|
WO2016205429A1
(en)
|
2015-06-15 |
2016-12-22 |
New York University |
Method of treatment using oncolytic viruses
|
US10188626B2
(en)
|
2015-11-03 |
2019-01-29 |
Cipla Limited |
Stabilized cabazitaxel formulations
|
BR112018075630A2
(pt)
|
2016-06-08 |
2019-03-19 |
Abbvie Inc. |
anticorpos anti-cd98 e conjugados de fármaco de anticorpo
|
JP6751165B2
(ja)
|
2016-06-08 |
2020-09-02 |
アッヴィ・インコーポレイテッド |
抗b7−h3抗体及び抗体薬物コンジュゲート
|
CN109562168A
(zh)
|
2016-06-08 |
2019-04-02 |
艾伯维公司 |
抗cd98抗体及抗体药物偶联物
|
CA3027044A1
(en)
|
2016-06-08 |
2017-12-14 |
Abbvie Inc. |
Anti-b7-h3 antibodies and antibody drug conjugates
|
BR112018075649A2
(pt)
|
2016-06-08 |
2019-04-09 |
Abbvie Inc. |
anticorpos anti-b7-h3 e conjugados de fármaco de anticorpo
|
JP6292267B2
(ja)
*
|
2016-09-13 |
2018-03-14 |
ニプロ株式会社 |
ドセタキセル製剤
|
EP3679925A4
(de)
|
2017-09-07 |
2021-04-21 |
Shenzhen Salubris Pharmaceuticals Co. Ltd |
Pharmazeutische zusammensetzung von docetaxelkonjugat und herstellungsverfahren
|
JP2018115178A
(ja)
*
|
2018-03-15 |
2018-07-26 |
ニプロ株式会社 |
ドセタキセル製剤
|
EP3823608A4
(de)
|
2018-09-05 |
2022-05-11 |
Emcure Pharmaceuticals Limited |
Stabile gebrauchsfertige pharmazeutische carmustinzusammensetzung
|
AR124681A1
(es)
|
2021-01-20 |
2023-04-26 |
Abbvie Inc |
Conjugados anticuerpo-fármaco anti-egfr
|